Lisa Gillen
- Pharmacology top 2%
- Pharmacology top 10%
- Oncology
- Cardiology and Cardiovascular Medicine
- Pediatrics, Perinatology and Child Health
- Co-authors
- Scott A. WaldmanHoward GreenbergWalter W. HauckMaria Luisa VeroneseBarbara A. OsborneE PéquignotJoanne BurkeKeith Gottesdiener
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Antiplatelet Therapy and Cardiovascular Diseases (4 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)
- Cited by
- PharmacologyBiochemistry
- Partner nations
- United StatesJordanFrance
In The Last Decade
Lisa Gillen
12 papers receiving 419 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 241
- Pharmacology 162
- Oncology 124
- Cardiology and Cardiovascular Medicine 72
- Pediatrics, Perinatology and Child Health 50
Countries citing papers authored by Lisa Gillen
This map shows the geographic impact of Lisa Gillen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Gillen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Gillen more than expected).
Fields of papers citing papers by Lisa Gillen
This network shows the impact of papers produced by Lisa Gillen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Gillen. The network helps show where Lisa Gillen may publish in the future.
Co-authorship network of co-authors of Lisa Gillen
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Gillen. A scholar is included among the top collaborators of Lisa Gillen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Gillen. Lisa Gillen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 112 | |
| 3 | 23 | |
| 4 | 35 | |
| 5 | A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. | 63 |
| 6 | 16 | |
| 7 | 49 | |
| 8 | 6 | |
| 9 | 59 | |
| 10 | 2 | |
| 11 | 28 | |
| 12 | 17 |
About Lisa Gillen
Lisa Gillen is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry, having authored 12 papers that have together received 437 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmacology (241 citations), Pharmacology (162 citations) and Biochemistry (40 citations). Lisa Gillen has collaborated with scholars based in United States, Jordan and France. Frequent co-authors include Scott A. Waldman, Howard Greenberg, Walter W. Hauck, Maria Luisa Veronese, Barbara A. Osborne, E Péquignot, Joanne Burke, Keith Gottesdiener, Martha Huntington and Peggy Wong. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.